The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
The Joint Corp.NASDAQ: JYNT
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables dips below year-ago levels
Q1 FY2026 accounts receivables of $460.37K fell 68.5% year over year, behind the +183.8% change in trailing-twelve-month accounts receivables. Sequentially, it rose 552.7% from the prior quarter.
Context
- Accounts receivables amounted to 2.8% of revenue in FY2025, down 0.4 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -68.5% toward the trailing-twelve-month pace of +183.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 1.53M USD
- Year-over-year change
- +193.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.53M | +193.3% |
| FY2024 | 2024-12-31 | (1.65M) | -955.3% |
| FY2023 | 2023-12-31 | 192.35K | +224.4% |
| FY2022 | 2022-12-31 | (154.67K) | +90.6% |
| FY2021 | 2021-12-31 | (1.64M) | — |
Accounts Receivables vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 accounts receivables of $532.37K is the 7th largest of the 11 companies compared; the peer median is $73.5K.
- Its year-over-year change of +183.8% is the 3rd highest of 9, against a peer median of -49.3%.
- Accounts receivables amounts to 0.9% of revenue for JYNT, versus a peer median of 8.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $78.26M | -17.7% | — | 25.9% | |
| LTM Mar 2026 | $1.84M | -561.0% | — | 5.4% | |
| LTM Mar 2026 | $1.31M | -404.9% | — | 2.3% | |
| LTM Mar 2026 | $1.17M | +191.7% | -42.5% | 0.9% | |
| LTM Mar 2026 | $1.12M | +128.6% | +72.7% | — | |
| LTM Mar 2026 | $631K | +5158.3% | — | 12.3% | |
| LTM Mar 2026 | $532.37K | +183.8% | — | 0.9% | |
| LTM Mar 2026 | $195.91K | — | — | 49.4% | |
| LTM Mar 2026 | $147K | -92.0% | -15.0% | 0.1% | |
| LTM Mar 2026 | $14K | -80.8% | — | 24.6% | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding JYNT) | $73.5K | -49.3% | -15.0% | 8.8% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.57M | 626.71K | (9.75M) | (8.53M) | 2.91M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| Deferred Income Tax | (1.78M) | (441.35K) | 10.9M | (55.56K) | 93.07K |
| Stock-Based Compensation | 1.06M | 1.27M | 1.74M | 1.68M | 1.3M |
| Change in Working Capital | 3.09M | (238.06K) | 798.62K | 1.1M | (9.56M) |
| Accounts Receivables | (1.64M) | (154.67K) | 192.35K | (1.65M) | 1.53M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (14.37K) | 818.27K | (1.38M) | 68.26K | (391.13K) |
| Other Working Capital | 4.74M | (901.65K) | 1.99M | 2.68M | (10.7M) |
| Other Non-Cash Items | (7.77K) | 341.68K | 2.41M | 10.5M | 5.39M |
| Operating Cash Flow | 13.84M | 8.21M | 14.68M | 9.42M | 1.84M |
| Capital Expenditures | (6.99M) | (5.9M) | (5M) | (1.19M) | (1.5M) |
| Acquisitions (Net) | (5.77M) | (12.11M) | (1.19M) | 554.1K | 7.78M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 105.2K | 0 | 0 | 0 |
| Investing Cash Flow | (12.75M) | (17.9M) | (6.19M) | (631.55K) | 6.27M |
| Debt Repayment | (2.81M) | (49.86K) | (24.43K) | (2.03M) | (4.35K) |
| Common Stock Issued | 0 | 0 | 202.39K | 33.71K | 1.52M |
| Common Stock Repurchased | 0 | (5.8K) | (3.83K) | (9.58K) | (11.32M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 811.59K | 384.27K | 0 | 0 | 0 |
| Financing Cash Flow | (2M) | 328.61K | 174.12K | (2M) | (9.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (907.29K) | (9.36M) | 8.66M | 6.78M | (1.69M) |
| Free Cash Flow | 6.85M | 2.31M | 9.68M | 8.23M | 334.72K |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.